Noninvasive assessment of liver fibrosis

Clinics in Liver Disease

Volumn 9, Issue 4, 2005, Pages 667-683

  Kelleher, T Barry ^a   Afdhal, Nezam ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA 2 GLOBULIN; ALPHA 2 MACROGLOBULIN; AMINOTRANSFERASE; APOLIPOPROTEIN A1; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; CHOLESTEROL; CHONDREX PROTEIN; COLLAGEN; CYTOKINE; GAMMA GLUTAMYLTRANSFERASE; GLYCOSAMINOGLYCAN; HYALURONIC ACID; IMMUNOGLOBULIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PROTEOGLYCAN; PROTHROMBIN; SCLEROPROTEIN; UNCLASSIFIED DRUG;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; AMPLITUDE MODULATION; ASSAY; BILIARY EXCRETION; BIOSYNTHESIS; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; COLLAGEN SYNTHESIS; COMPUTER ASSISTED TOMOGRAPHY; DEGRADATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ECHOGRAPHY; ELASTOGRAPHY; EXTRACELLULAR MATRIX; FIBROGENESIS; FREQUENCY MODULATION; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYPERSPLENISM; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; METABOLIC DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL HYPERTENSION; RADIOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SAMPLING; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SERUM; THROMBOCYTE COUNT; THROMBOCYTOPENIA; ULTRASOUND TRANSDUCER; URINARY EXCRETION; VIBRATION;

BIOLOGICAL MARKERS; BIOPSY; HUMANS; LIVER CIRRHOSIS;

EID: 26044469442     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2005.08.002     Document Type: Review

References (81)

1. C. Pilette, M.C. Rousselet, and P. Bedossa Histopathological evaluation of liver fibrosis: quantitative image analysis vs semiquantitative scores. Comparison with serum markers J Hepatol 28 1998 439 446
2. A. Regev, M. Berho, and L.J. Jeffers Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection Am J Gastroenterol 97 2002 2614 2618
3. F. Imbert-Bismut, V. Ratziu, and L. Pieroni Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study Lancet 357 2001 1069 1075
4. T. Poynard, J. McHutchison, and M. Manns Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin Hepatology 38 2003 481 492
5. W.P. Harbin, N.J. Robert, and J.T. Ferrucci Jr Diagnosis of cirrhosis based on regional changes in hepatic morphology: a radiological and pathological analysis Radiology 135 1980 273 283
6. M. Ziol, A. Handra-Luca, and A. Kettaneh Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C Hepatology 41 2004 48 54
7. A. Bingel Über die Parenchympunktion der Leber Verh Dtsch Ges Inn Med 35 1923 210 212
8. A.A. Bravo, S.G. Sheth, and S. Chopra Liver biopsy N Engl J Med 344 2001 495 500
9. F. Froehlich, O. Lamy, and M. Fried Practice and complications of liver biopsy. Results of a nationwide survey in Switzerland Dig Dis Sci 38 1993 1480 1484
10. K.D. Lindor, C. Bru, and R.A. Jorgensen The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy Hepatology 23 1996 1079 1083
11. J. Perrault, D.B. McGill, and B.J. Ott Liver biopsy: complications in 1000 inpatients and outpatients Gastroenterology 74 1978 103 106
12. P. Thampanitchawong, and T. Piratvisuth Liver biopsy: complications and risk factors World J Gastroenterol 5 1999 301 304
13. B. Terjung, I. Lemnitzer, and F.L. Dumoulin Bleeding complications after percutaneous liver biopsy. An analysis of risk factors Digestion 67 2003 138 145
14. B. Maharaj, R.J. Maharaj, and W.P. Leary Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver Lancet 1 1986 523 525
15. L. Pagliaro, F. Rinaldi, and A. Craxi Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. A prospective, randomized trial Dig Dis Sci 28 1983 39 43
16. J. Poniachik, D.E. Bernstein, and K.R. Reddy The role of laparoscopy in the diagnosis of cirrhosis Gastrointest Endosc 43 1996 568 571
17. M.C. Garrido, and S.G. Hubscher Accuracy of staging in primary biliary cirrhosis J Clin Pathol 49 1996 556 559
18. W. Abdi, J.C. Millan, and E. Mezey Sampling variability on percutaneous liver biopsy Arch Intern Med 139 1979 667 669
19. P. Bedossa, D. Dargere, and V. Paradis Sampling variability of liver fibrosis in chronic hepatitis C Hepatology 38 2003 1449 1457
20. T. Poynard, M. Munteanu, and F. Imbert-Bismut Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C Clin Chem 50 2004 1344 1355
21. P. Schlichting, L. Fauerholdt, and E. Christensen Clinical relevance of restrictive morphological criteria for the diagnosis of cirrhosis in liver biopsies Liver 1 1981 56 61
22. P. Bedossa, T. Poynard, and S. Naveau Observer variation in assessment of liver biopsies of alcoholic patients Alcohol Clin Exp Res 12 1988 173 178
23. J. Westin, L.M. Lagging, and R. Wejstal Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection Liver 19 1999 183 187
24. M.J. O'Brien, N.M. Keating, and S. Elderiny An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C Am J Clin Pathol 114 2000 712 718
25. A.M. Zaitoun, H. Al Mardini, and S. Awad Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C J Clin Pathol 54 2001 461 465
26. C. Aube, F. Oberti, and N. Korali Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis J Hepatol 30 1999 472 478
27. S. Gaiani, L. Gramantieri, and N. Venturoli What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy J Hepatol 27 1997 979 985
28. N.H. Afdhal, and D. Nunes Evaluation of liver fibrosis: a concise review Am J Gastroenterol 99 2004 1160 1174
29. L. Sandrin, B. Fourquet, and J.M. Hasquenoph Transient elastography: a new noninvasive method for assessment of hepatic fibrosis Ultrasound Med Biol 29 2003 1705 1713
30. L. Sandrin, M. Tanter, and J.L. Gennisson Shear elasticity probe for soft tissues with 1-D transient elastography IEEE Trans Ultrason Ferroelectr Freq Control 49 2002 436 446
31. W.C. Yeh, P.C. Li, and Y.M. Jeng Elastic modulus measurements of human liver and correlation with pathology Ultrasound Med Biol 28 2002 467 474
32. S.L. Friedman Liver fibrosis-from bench to bedside J Hepatol 38 Suppl 1 2003 S38 S53
33. L. Castera, D.J. Hartmann, and F. Chapel Serum laminin and type IV collagen are accurate markers of histologically severe alcoholic hepatitis in patients with cirrhosis J Hepatol 32 2000 412 418
34. A. Hayasaka, D. Schuppan, and K. Ohnishi Serum concentrations of the carboxyterminal cross-linking domain of procollagen type IV (NC1) and the aminoterminal propeptide of procollagen type III (PIIIP) in chronic liver disease J Hepatol 10 1990 17 22
35. A. Kasahara, N. Hayashi, and K. Mochizuki Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon response J Hepatol 26 1997 574 583
36. J.G. McHutchison, L.M. Blatt, and M. de Medina Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group J Gastroenterol Hepatol 15 2000 945 951
37. Y. Murawaki, Y. Ikuta, and M. Koda Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology Hepatology 20 1994 780 787
38. Y. Murawaki, Y. Ikuta, and K. Okamoto Serum matrix metalloproteinase-3 (stromelysin-1) concentration in patients with chronic liver disease J Hepatol 31 1999 474 481
39. D. Schuppan, M.C. Cantaluppi, and J. Becker Undulin, an extracellular matrix glycoprotein associated with collagen fibrils J Biol Chem 265 1990 8823 8832
40. J.C. Trinchet Clinical use of serum markers of fibrosis in chronic hepatitis J Hepatol 22 1995 89 95
41. M. Yamauchi, Y. Mizuhara, and Y. Maezawa Serum tenascin levels in chronic liver disease Liver 14 1994 148 153
42. X. Forns, S. Ampurdanes, and J.M. Llovet Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model Hepatology 36 2002 986 992
43. D. Thabut, M. Simon, and R.P. Myers Noninvasive prediction of fibrosis in patients with chronic hepatitis C Hepatology 37 2003 1220 1221
44. C.T. Wai, J.K. Greenson, and R.J. Fontana A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 2003 518 526
45. S.G. Sheth, S.L. Flamm, and F.D. Gordon AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection Am J Gastroenterol 93 1998 44 48
46. E. Giannini, F. Botta, and P. Borro Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis Gut 52 2003 1200 1205
47. V. Croquet, E. Vuillemin, and C. Ternisien Prothrombin index is an indirect marker of severe liver fibrosis Eur J Gastroenterol Hepatol 14 2002 1133 1141
48. G.J. Park, B.P. Lin, and M.C. Ngu Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis? J Gastroenterol Hepatol 15 2000 386 390
49. N. Assy, and G.Y. Minuk Serum aspartate but not alanine aminotransferase levels help to predict the histological features of chronic hepatitis C viral infections in adults Am J Gastroenterol 95 2000 1545 1550
50. E. Giannini, D. Risso, and F. Botta Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease Arch Intern Med 163 2003 218 224
51. T. Poynard, A. Aubert, and P. Bedossa A simple biological index for detection of alcoholic liver disease in drinkers Gastroenterology 100 1991 1397 1402
52. F. Oberti, E. Valsesia, and C. Pilette Noninvasive diagnosis of hepatic fibrosis or cirrhosis Gastroenterology 113 1997 1609 1616
53. J.P. Teare, D. Sherman, and S.M. Greenfield Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis Lancet 342 1993 895 898
54. R.P. Myers, Y. Benhamou, and F. Imbert-Bismut Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus coinfected patients AIDS 17 2003 721 725
55. R.P. Myers, M. De Torres, and F. Imbert-Bismut Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index Dig Dis Sci 48 2003 146 153
56. E. Rossi, L. Adams, and A. Prins Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients Clin Chem 49 2003 450 454
57. L. Castera, J. Vergniol, and J. Foucher Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C Gastroenterology 128 2005 343 350
58. P. Halfon, F. Imbert-Bismut, and D. Messous A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease Comp Hepatol 1 2002 3
59. T. Poynard, F. Imbert-Bismut, and M. Munteanu Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C Comp Hepatol 3 2004 8
60. T. Kawasaki, A. Takeshita, and K. Souda Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis Am J Gastroenterol 94 1999 1918 1922
61. R.H. Aster Pooling of platelets in the spleen: role in the pathogenesis of hypersplenic thrombocytopenia J Clin Invest 45 1966 645 657
62. Y. Kamimoto, S. Horiuchi, and S. Tanase Plasma clearance of intravenously injected aspartate aminotransferase isozymes: evidence for preferential uptake by sinusoidal liver cells Hepatology 5 1985 367 375
63. J. Guechot, A. Laudat, and A. Loria Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis Clin Chem 42 1996 558 563
64. G. Montalto, M. Soresi, and F. Aragona Procollagen III and laminin in chronic viral hepatopathies Presse Med 25 1996 59 62
65. J.C. Trinchet, D.J. Hartmann, and D. Pateron Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. Relationship to liver histology and conventional liver tests J Hepatol 12 1991 139 144
66. E. Hahn, G. Wick, and D. Pencev Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin Gut 21 1980 63 71
67. D.K. George, G.A. Ramm, and N.I. Walker Elevated serum type IV collagen: a sensitive indicator of the presence of cirrhosis in haemochromatosis J Hepatol 31 1999 47 52
68. Y. Murawaki, Y. Ikuta, and M. Koda Comparison of serum 7S fragment of type IV collagen and serum central triple-helix of type IV collagen for assessment of liver fibrosis in patients with chronic viral liver disease J Hepatol 24 1996 148 154
69. T. Ninomiya, S. Yoon, and Y. Hayashi Clinical significance of serum hyaluronic acid as a fibrosis marker in chronic hepatitis C patients treated with interferon-alpha: histological evaluation by a modified histological activity index scoring system J Gastroenterol Hepatol 13 1998 68 74
70. R.C. Benyon, J.P. Iredale, and S. Goddard Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver Gastroenterology 110 1996 821 831
71. J.P. Iredale, S. Goddard, and G. Murphy Tissue inhibitor of metalloproteinase-I and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes Clin Sci (Lond) 89 1995 75 81
72. K.H. Boeker, C.I. Haberkorn, and D. Michels Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C Clin Chim Acta 316 2002 71 81
73. C. Nojgaard, J.S. Johansen, and E. Christensen Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease J Hepatol 39 2003 179 186
74. K.M. Walsh, P. Timms, and S. Campbell Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases -1 and -2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: comparison using ROC analysis Dig Dis Sci 44 1999 624 630
75. J.S. Johansen, P. Christoffersen, and S. Moller Serum YKL-40 is increased in patients with hepatic fibrosis J Hepatol 32 2000 911 920
76. C. Nojgaard, J.S. Johansen, and H.B. Krarup Effect of antiviral therapy on markers of fibrogenesis in patients with chronic hepatitis C Scand J Gastroenterol 38 2003 659 665
77. D.R. Nelson, R.P. Gonzalez-Peralta, and K. Qian Transforming growth factor-beta 1 in chronic hepatitis C J Viral Hepat 4 1997 29 35
78. S. Kanzler, M. Baumann, and P. Schirmacher Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-beta J Viral Hepat 8 2001 430 437
79. K. Patel, S.C. Gordon, and I. Jacobson Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients J Hepatol 41 2004 935 942
80. W.M. Rosenberg, M. Voelker, and R. Thiel Serum markers detect the presence of liver fibrosis: a cohort study Gastroenterology 127 2004 1704 1713
81. T. Kelleher, S. Mehta, and R. Bhaskar Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: The SHASTA index J Hepatol 43 1 2005 78 84